Memorial Sloan - Kettering Cancer Center

Memorial Sloan Kettering Cancer Center — the world’s oldest and largest private cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, they are one of 41 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.

The close collaboration between their physicians and scientists is one of their unique strengths, enabling us to provide patients with the best care available as they work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Their education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world.

Memorial Sloan - Kettering Cancer Center, established in 1884 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Biotechnology, Life Science, Health Care, Biopharma, Medical Device, Pharmaceutical, Medical, Precision Medicine, Finance, Business Development. The organization boasts a portfolio of 6 investments, with an average round size of $54.6M and 1 successful exits. Their recent investments include Flare Therapeutics, Third Rock Ventures, Novartis, Invus, Eli Lilly. The highest investment round they participated in was $49.2B. Among their most notable exits are Flare Therapeutics and Third Rock Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.